| RS1364739747 |
CTNNA3
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 13, Arrhythmogenic right ventricular dysplasia 13 |
| RS1364754878 |
ALOX12B
|
Health Risk |
Pathogenic |
Autosomal recessive congenital ichthyosis 2, Autosomal recessive congenital ichthyosis 2 |
| RS1364768386 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1364773011 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS1364773484 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiovascular phenotype |
| RS1364779690 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1364780551 |
QDPR
|
Health Risk |
Likely pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS1364784378 |
GNPTAB
|
Health Risk |
Likely pathogenic |
Mucolipidosis, Mucolipidosis type II |
| RS1364784964 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder |
| RS1364796862 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1364800683 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS1364808920 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1364819755 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1364823765 |
TYR
|
Health Risk |
Pathogenic |
TYR-related disorder, SKIN/HAIR/EYE PIGMENTATION 3 |
| RS1364834942 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS1364860348 |
ANO5
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2L, Autosomal recessive limb-girdle muscular dystrophy type 2L |
| RS1364913665 |
LGI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal dominant epilepsy with auditory features, Epilepsy |
| RS1364945778 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 14, CEP290-related disorder |
| RS1364947213 |
VPS13B
|
Health Risk |
Likely pathogenic |
6 conditions, High myopia |
| RS1364950881 |
MKS1
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1364953579 |
SLC1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1364954371 |
KIAA0586
|
Health Risk |
Pathogenic |
Short-rib thoracic dysplasia 14 with polydactyly, Joubert syndrome 23 |
| RS1364961973 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1364971527 |
HIBCH
|
Health Risk |
Pathogenic/Likely pathogenic |
3-hydroxyisobutyryl-CoA hydrolase deficiency, See cases |
| RS1364973121 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS1364976535 |
PKD1
|
Health Risk |
Pathogenic |
Polycystic kidney disease, adult type |
| RS1364987785 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2, Retinitis pigmentosa 39 |
| RS1364998040 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS1365010331 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1365010493 |
PHEX
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1365019056 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS1365019676 |
ROR2
|
Health Risk |
Pathogenic |
Autosomal recessive Robinow syndrome, Autosomal recessive Robinow syndrome |
| RS1365022834 |
NPHP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome with renal defect, Nephronophthisis 1 |
| RS1365042239 |
LMNA
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Cardiovascular phenotype |
| RS1365047750 |
PEX1
|
Health Risk |
Likely pathogenic |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1365049763 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1365085828 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS1365128831 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1365148358 |
COL7A1
|
Health Risk |
Likely pathogenic |
— |
| RS1365173817 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1365226221 |
CR2
|
Health Risk |
Likely pathogenic |
Immunodeficiency, common variable |
| RS1365230067 |
CBL
|
Health Risk |
Conflicting classifications of pathogenicity |
RASopathy, Cardiovascular phenotype |
| RS1365239366 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS1365249537 |
COL6A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1365275304 |
DNAH5
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1365305675 |
BRWD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1365308037 |
PNPT1
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 13, Combined oxidative phosphorylation defect type 13 |
| RS1365337213 |
APOA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS1365354712 |
TCF12
|
Health Risk |
Pathogenic |
Developmental delay, Developmental delay |
| RS1365372289 |
ADCY5
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Dyskinesia with orofacial involvement |
| RS1365389365 |
TMEM43
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 5 |
| RS1365390122 |
EIF2B2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1365404018 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Inborn genetic diseases |
| RS1365407882 |
PKHD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS1365414881 |
BBS12
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS1365439707 |
IFT81
|
Health Risk |
Likely pathogenic |
— |
| RS1365445365 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Chuvash polycythemia, Von Hippel-Lindau syndrome |
| RS1365446658 |
GYG1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease XV, Polyglucosan body myopathy type 2 |
| RS1365450066 |
COL18A1
|
Health Risk |
Pathogenic |
Knobloch syndrome 1, Knobloch syndrome 1 |
| RS1365453773 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1365461027 |
PCYT2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1365470411 |
SLC26A3
|
Health Risk |
Pathogenic |
— |
| RS1365474284 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1365479526 |
DNMT3A
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1365490247 |
CACNA1F
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1365502451 |
PKHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive polycystic kidney disease, PKHD1-related disorder |
| RS1365563478 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1365580904 |
ADAMTS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, dermatosparaxis type |
| RS1365611175 |
ARX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS1365616275 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1365620880 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1365622597 |
ZYG11B
|
Health Risk |
Likely pathogenic |
Craniofacial microsomia 1, Craniofacial microsomia 1 |
| RS1365625070 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1365632054 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1365665482 |
SEC24D
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1365669334 |
RP1
|
Health Risk |
Pathogenic |
RP1-related recessive retinopathy, RP1-related recessive retinopathy |
| RS1365675953 |
PCARE
|
Health Risk |
Pathogenic |
— |
| RS1365687375 |
ASXL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1365691434 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rothmund-Thomson syndrome type 2, Rothmund-Thomson syndrome type 2 |
| RS1365700579 |
YARS2
|
Health Risk |
Pathogenic |
Mitochondrial disease, Mitochondrial disease |
| RS1365704916 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease recessive intermediate C, Neuronopathy |
| RS1365723695 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS1365726807 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1365746397 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1365753930 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1365770233 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS1365774406 |
SCN2A
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 11 |
| RS1365778107 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Classic or attenuated familial adenomatous polyposis |
| RS1365780833 |
FLG
|
Health Risk |
Likely pathogenic |
Ichthyosis vulgaris, Ichthyosis vulgaris |
| RS1365799072 |
COL11A2
|
Health Risk |
Pathogenic |
— |
| RS1365818420 |
SMOC1
|
Health Risk |
Pathogenic |
Microphthalmia with limb anomalies, Microphthalmia with limb anomalies |
| RS1365849986 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1365856881 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Central core myopathy |
| RS1365858851 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1365879789 |
UBE3B
|
Health Risk |
Pathogenic |
— |
| RS1365908727 |
RP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, RP1-related disorder |
| RS1365923535 |
SGCB
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2E, Autosomal recessive limb-girdle muscular dystrophy type 2E |
| RS1365926067 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Intellectual disability |
| RS1365926616 |
CNGB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Retinal dystrophy |
| RS1365970060 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group D2 |